Izzat Othman - Millennium Pharmacon President Commissioner, Independent Commissioner
| SDPC Stock | IDR 147.00 5.00 3.52% |
President
Mr. Izzat bin Othman serves as President Commissioner, Independent Commissioner of PT Millennium Pharmacon International Tbk since July 9, 2015. He was appointed as Independent Commissioner on May 26, 2011. He serves as Partner of law firm of Messrs. Azzat Izzat. He graduated with an LLB in April 1985 from Universiti Malaya. Subsequently, he was admitted as an Advocate and Solicitor on January 25, 1986. He was formerly a Director in AFFIN Securities Sdn Bhd and BH Insurance Berhad and has experience relating to litigation, conveyancing and corporate matters. He also sits as Chairman and committee member for the Disciplinary Committee of the Malaysian Bar, as well as Board of Directors for several private companies. since 2015.
| Age | 56 |
| Tenure | 9 years |
| Phone | 62 21 270 85961 |
| Web | https://www.mpi-indonesia.co.id |
Millennium Pharmacon Management Efficiency
The company has return on total asset (ROA) of 0.0342 % which means that it generated a profit of $0.0342 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0938 %, meaning that it generated $0.0938 on every $100 dollars invested by stockholders. Millennium Pharmacon's management efficiency ratios could be used to measure how well Millennium Pharmacon manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 2 records | PRESIDENT Age | ||
| Edwin Soeryadjaya | Saratoga Investama Sedaya | 74 | |
| Benny Haryanto | Lenox Pasifik Investama | 57 | |
Management Performance
| Return On Equity | 0.0938 | |||
| Return On Asset | 0.0342 |
Millennium Pharmacon Leadership Team
Elected by the shareholders, the Millennium Pharmacon's board of directors comprises two types of representatives: Millennium Pharmacon inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Millennium. The board's role is to monitor Millennium Pharmacon's management team and ensure that shareholders' interests are well served. Millennium Pharmacon's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Millennium Pharmacon's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Mohamad Hassan, F Director | ||
| Glenn Ariff, Unaffiliated Director | ||
| Aris, Chairman Audit | ||
| Dian Anggreni, Legal and Corporate Secretary | ||
| Ernie Hilal, Corporate Secretary | ||
| Yungkis Sucandra, Head Unit | ||
| Ahmad Bakar, Pres Director | ||
| Mohamad Mukhtar, President Director | ||
| Morsela, Ma Marketing | ||
| Puji Hartono, Head Unit | ||
| Nyoman Rai, Independent Commissioner | ||
| Dedi Martadiredja, Sr Sales | ||
| Ivan Hanafi, Independent Director | ||
| Olga Bolang, Co Sec | ||
| Noraini Ali, Commissioner | ||
| Izzat Othman, President Commissioner, Independent Commissioner | ||
| Yuni Arrivani, Deputy Legal | ||
| Mohamed Rahman, Commissioner |
Millennium Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Millennium Pharmacon a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0938 | |||
| Return On Asset | 0.0342 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | 0.02 % | |||
| Current Valuation | 828.27 B | |||
| Shares Outstanding | 1.27 B | |||
| Shares Owned By Insiders | 87.94 % | |||
| Shares Owned By Institutions | 3.35 % | |||
| Price To Earning | 9.31 X | |||
| Price To Book | 1.16 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Millennium Pharmacon in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Millennium Pharmacon's short interest history, or implied volatility extrapolated from Millennium Pharmacon options trading.
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Millennium Pharmacon International. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the AI Investment Finder module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for Millennium Stock analysis
When running Millennium Pharmacon's price analysis, check to measure Millennium Pharmacon's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Millennium Pharmacon is operating at the current time. Most of Millennium Pharmacon's value examination focuses on studying past and present price action to predict the probability of Millennium Pharmacon's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Millennium Pharmacon's price. Additionally, you may evaluate how the addition of Millennium Pharmacon to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |